Human prothrombin complex(Chengdu Rongsheng Pharmaceuticals)

人凝血酶原复合物（成都蓉生药业）

Report date: 2026/03/04 20:01:44

Base Information

Drug NameHuman prothrombin complex(Chengdu Rongsheng Pharmaceuticals)
Drug Alias Name人凝血酶原复合物
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIICoagulation factor XCoagulation factor IX +[4] 
Therapy Area/IndicationsCoagulation Protein DisordersHemophilia B
Global Approved IndicationsCoagulation Protein Disorders
Approved Indications in ChinaCoagulation Protein Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date2020/12/15
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChengdu Rongsheng Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Rongsheng Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsCoagulation Protein Disorders
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A